Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell- mediated cytotoxicity

Transplantation

Volumn 63, Issue 12, 1997, Pages 1782-1789

  Sparrelid, Elda ^a,c   Emanuel, David ^b   Fehniger, Thomas ^a   Andersson, Ulf ^d   Andersson, Jan ^d  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOTOXIN; METHOTREXATE; MONOCLONAL ANTIBODY; PERFORIN; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; PHENOTYPE; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; ANTIGENS, VIRAL; APOPTOSIS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; PHENOTYPE; PHOSPHOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TH2 CELLS; VIRAL MATRIX PROTEINS;

EID: 0030996546     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706270-00013     Document Type: Article

References (40)

1. Meyers JD. Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention. In: Plotkin SA, Michelson S, Pagano JS, et al., eds. CMV: pathogenesis and prevention of human infection. New York: Liss, 1984: 101.
2. Reddehase MJ, Balthesen M, Rapp M, Jonjié S, Pavié I, Koszinowski UH. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 1994; 179: 185.
3. Reddehase MJ, Mutter W, Münch K, Būhring HJ, Koszinowski UH. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987; 61: 3102.
4. Zinkernagel R. Increased susceptibility to virus infection in perforin knock out mice. Nature 1995; 378: 14.
5. Bowden RA, Mori M, Dobbs S, Hackman R, Kopecky K, Crawford S. Mononuclear cell reconstitution in the lung after marrow transplantation. Transplantation 1993; 55: 557.
6. Bowden RA, Day LM, Amos DE, Meyers JD. Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation. Transplantation 1987; 44: 504.
7. Bowden RA, Dobbs S, Amos D, Meyers J. Comparison of interleukin 2 and gamma interferon production by peripheral blood mononuclear cells in response to cytomegalovirus after marrow transplantation. Transplantation 1990; 50: 38.
8. Meyers JD. Infection in recipients of marrow transplants. In: Remington JS, Swartz MN, eds. Current clinical topics in infectious diseases. New York: McGraw-Hill, 1985: 261.
9. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation I and II. N Engl J Med 1975; 292: 832, 895.
10. Emanuel D, Cunningham I, Jules-Elysee K, et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777.
11. Andersson J, Abrams J, Björk L, et al. Concomitant in vivo production of 19 different cytokines in humans tonsils. Immunology 1994; 83: 16.
12. Andersson J, Björk L, Dinarello CA, Towbin H, Andersson U. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992; 22: 2617.
13. Abrams JS, Roncarolo HG, Yssel H, Andersson U, Gleich GL, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1993; 127: 5.
14. Björk L, Andersson J, Ceska M, Andersson U. Endotoxin and Staphylococcus aureus enterotoxin A induce different patterns of cytokines. Cytokine 1992; 4(6): 513.
15. Sieling PA, Wong X, Gately MK, et al. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 1994; 153: 3639.
16. Andersson U, Adolf G, Dohlsten M, Möller G, Sjögren HO. Characterization of individual tumor necrosis factor α and β producing cells after polyclonal T cell activation. J Immunol Methods 1989; 123: 233.
17. Andersson G, Ekre HP, Alm G, Perlmann P. Monoclonal antibody two-site ELISA for human IFNγ. J Immunol 1990; 125: 89.
18. Olofsson A, Miyanzono K, Kanzaki T, Colosetti P, Engström U, Heldin CH. Transforming growth factor-1, -2, -3 secreted by human glioblastoma cell line. J Biol Chem 1992; 267: 19482.
19. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81: 1607.
20. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747.
21. Tian Q, Strauli M, Saito H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation. Cell 1991; 67: 629.
22. Tschopp J, Nabholz M. Perforin mediated target cell lysis by cytotoxic T lymphocytes. Annu Rev Immunol 1990; 8: 279.
23. Gravrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493.
24. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994; 372: 100.
25. Genne DE, Tschopp I. Granzymes, a family of cerine proteases released from granules of cytotoxic T lymphocytes upon T cell receptor stimulation. Immunol Rev 1988; 103: 53-65.
26. Borysiewicz LK, Hickling JK, Graham S, et al. Human cytomegalovirus-specific cytotoxic T cells. J Exp Med 1988; 168: 919.
27. Jonjic S, Pavic I, Plic B, Crnkovic I, Lucin P, Koszinowski UH. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 1994; 179: 1713.
28. Quinnan GV Jr, Kirmani N, Rook AH, et al. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone marrow-transplant recipients. N Engl J Med 1982; 307: 7.
29. Reusser P, Riddell SR, Myers JD, Greenberg PD. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78: 1373.
30. Reddehase MJ, Mutter W, Munch K, Buhring HJ, Koszinowski UH. CD 8-positive lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987; 61: 3102.
31. Redderhase MJ, Weiland F, Munch K, Jonic S, Luske A, Koszinowski UH. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 1985; 55: 264.
32. Riddell SR, Watanabe KS, Goodrich JM, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992; 257: 238.
33. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038.
34. McLaughlin-Taylor E, Pande H, Forman SJ, et al. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 1994; 43: 103.
35. Salgame PR, Abrams JS, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279.
36. Street NE, Mosman TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5: 171.
37. Hess AD, Tutschka J, Santos GW. Effect of cyclosporin A on human lymphocyte responses in vitro: III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the responses of primed lymphocytes to TCGF. J Immunol 1982; 128: 355.
38. Schneider LC, Antin JH, Weinstein H, et al. Lymphokine profile in bone marrow transplant recipients. Blood 1991; 78: 3076.
39. Orange JS, Wang B, Terhorst C, Biron C. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995; 182: 1045.
40. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFNγ production by T cells. Nature 1995; 378: 88.